Review



anti igf2 goat polyclonal antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems anti igf2 goat polyclonal antibody
    Figure 2. Serum <t>IGF2</t> isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.
    Anti Igf2 Goat Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 27 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2+goat+polyclonal+antibody/pm29897468-67-6-11?v=R%26D+Systems
    Average 94 stars, based on 27 article reviews
    anti igf2 goat polyclonal antibody - by Bioz Stars, 2026-07
    94/100 stars

    Images

    1) Product Images from "Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study."

    Article Title: Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study.

    Journal: The Journal of clinical endocrinology and metabolism

    doi: 10.1210/jc.2018-00593

    Figure 2. Serum IGF2 isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.
    Figure Legend Snippet: Figure 2. Serum IGF2 isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.

    Techniques Used: Comparison

    Figure 3. Comparative analysis of gene-expression levels in SFT using qRT-PCR. (A) IGF2 mRNA expression levels in the non-NICTH group and the NICTH group. (B) PCSK4 mRNA expression levels in the non-NICTH group and the NICTH group. (C) The IGF2/PCSK4 mRNA expression-level ratio in the non-NICTH group and the NICTH group. *P = 0.093, **P = 0.217, ***P = 0.006. P values were obtained using the t test. These values are not statistically significant but tentative as a result of the limited number of samples.
    Figure Legend Snippet: Figure 3. Comparative analysis of gene-expression levels in SFT using qRT-PCR. (A) IGF2 mRNA expression levels in the non-NICTH group and the NICTH group. (B) PCSK4 mRNA expression levels in the non-NICTH group and the NICTH group. (C) The IGF2/PCSK4 mRNA expression-level ratio in the non-NICTH group and the NICTH group. *P = 0.093, **P = 0.217, ***P = 0.006. P values were obtained using the t test. These values are not statistically significant but tentative as a result of the limited number of samples.

    Techniques Used: Gene Expression, Quantitative RT-PCR, Expressing

    Figure 4. Comparative analysis of protein expression levels in SFT by immunohistochemistry analysis. (A) Representative images of immunohistochemistry for IGF2. (B) Representative images of immunohistochemistry for PCSK4. (C) Comparison of IGF2 expression levels between the non-NICTH group and the NICTH group. (D) Comparison of PCSK4 expression levels between the non-NICTH group and the NICTH group. (E) Comparison of the IGF2/PCSK4 expression-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; (C and E) P , 0.05 was accepted as significant and is indicated in bold.
    Figure Legend Snippet: Figure 4. Comparative analysis of protein expression levels in SFT by immunohistochemistry analysis. (A) Representative images of immunohistochemistry for IGF2. (B) Representative images of immunohistochemistry for PCSK4. (C) Comparison of IGF2 expression levels between the non-NICTH group and the NICTH group. (D) Comparison of PCSK4 expression levels between the non-NICTH group and the NICTH group. (E) Comparison of the IGF2/PCSK4 expression-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; (C and E) P , 0.05 was accepted as significant and is indicated in bold.

    Techniques Used: Expressing, Immunohistochemistry, Comparison



    Similar Products

    90
    Santa Cruz Biotechnology goat polyclonal anti-igf2 f20 sc-7435
    List of antibodies and IgGs used for immunohistochemistry of equine endometrium and conceptus membranes.
    Goat Polyclonal Anti Igf2 F20 Sc 7435, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2+goat+polyclonal+antibody/pmc09513317-27-6-8?v=Santa+Cruz+Biotechnology
    Average 90 stars, based on 1 article reviews
    goat polyclonal anti-igf2 f20 sc-7435 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    94
    R&D Systems anti igf2 goat polyclonal antibody
    Figure 2. Serum <t>IGF2</t> isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.
    Anti Igf2 Goat Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2+goat+polyclonal+antibody/pm29897468-67-6-11?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    anti igf2 goat polyclonal antibody - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    R&D Systems goat anti human igf2 polyclonal antibody
    Figure 2. Serum <t>IGF2</t> isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.
    Goat Anti Human Igf2 Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2+goat+polyclonal+antibody/pmc04262567-111-6-11?v=R%26D+Systems
    Average 94 stars, based on 1 article reviews
    goat anti human igf2 polyclonal antibody - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology anti-igf2 goat polyclonal antibody sc-1415
    Expression of miR483-3p, IGF 2 and Smad4 in adrenocortical tumors
    Anti Igf2 Goat Polyclonal Antibody Sc 1415, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2+goat+polyclonal+antibody/pmc04282325-96-7-12?v=Santa+Cruz+Biotechnology
    Average 90 stars, based on 1 article reviews
    anti-igf2 goat polyclonal antibody sc-1415 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology polyclonal rabbit igg for igf2
    Nucleolus-enriched RNAs 1
    Polyclonal Rabbit Igg For Igf2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2+goat+polyclonal+antibody/pmc04615376-154-8-14?v=Santa+Cruz+Biotechnology
    Average 96 stars, based on 1 article reviews
    polyclonal rabbit igg for igf2 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    90
    R&D Systems goat polyclonal anti human igf ii
    Nucleolus-enriched RNAs 1
    Goat Polyclonal Anti Human Igf Ii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2+goat+polyclonal+antibody/10__1203_slash_pdr__0b013e3181425841-77-29-36?v=R%26D+Systems
    Average 90 stars, based on 1 article reviews
    goat polyclonal anti human igf ii - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    85
    R&D Systems biotin labeled goat polyclonal anti human igf ii
    Nucleolus-enriched RNAs 1
    Biotin Labeled Goat Polyclonal Anti Human Igf Ii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2+goat+polyclonal+antibody/10__1203_slash_pdr__0b013e3181425841-77-28-36?v=R%26D+Systems
    Average 85 stars, based on 1 article reviews
    biotin labeled goat polyclonal anti human igf ii - by Bioz Stars, 2026-07
    85/100 stars
      Buy from Supplier

    93
    R&D Systems igf2 goat polyclonal
    FIG. 5. Effect of H358-conditioned medium, AR, and IGF1 on IGF1-R tyrosine phosphorylation. Serum-deprived H322 cells were incubated: A, for 30 min in serum-free medium (), in serum-free medium with IGF1 50 ng/ml (IGF1), or for indicated times in serum-free H358 CM (CM); B, for 30 min in serum-free medium (), in H358 CM (CM), in H358 CM preincubated with anti-AR neutralizing antibody (CM Ac AR), or in serum-free medium with 50 ng/ml of IGF1 (IGF1) or AR (AR), prior to detergent lysis and immunoprecipitation of the IGF1-R subunit. C, serum-deprived H358 cells were incubated for 30 min in serum-free medium (), in H358 CM (CM), or in serum-free medium with 50 ng/ml of IGF1 (IGF1) or AR (AR), prior to detergent lysis and immunoprecipitation of the IGF1-R subunit. Tyrosine phos- phorylation was visualized by protein immunoblotting with monoclonal anti-phosphotyrosine IgG as described (upper lane). Equal loading of immunoprecipitated proteins was confirmed by reprobing immunoblots with <t>polyclonal</t> anti-IGF1-R subunit antibody (lower lane). IgG, im- munoglobulin control for immunoprecipitation. Data are representative of at least three separate experiments.
    Igf2 Goat Polyclonal, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+igf2+goat+polyclonal+antibody/10__1074_slash_jbc__m207584200-61-11-14?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    igf2 goat polyclonal - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    Image Search Results


    List of antibodies and IgGs used for immunohistochemistry of equine endometrium and conceptus membranes.

    Journal: Frontiers in Veterinary Science

    Article Title: Insulin-like growth factor system components expressed at the conceptus-maternal interface during the establishment of equine pregnancy

    doi: 10.3389/fvets.2022.912721

    Figure Lengend Snippet: List of antibodies and IgGs used for immunohistochemistry of equine endometrium and conceptus membranes.

    Article Snippet: IGF2 , Goat polyclonal anti-IGF2 , F20 sc-7435 Santa Cruz (1: 50) , Biotinylated rabbit anti-goat , BA-5000, Vector Laboratories Inc. , Goat IgG (1: 100).

    Techniques: Immunohistochemistry, Control, Plasmid Preparation

    Figure 2. Serum IGF2 isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.

    Journal: The Journal of clinical endocrinology and metabolism

    Article Title: Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study.

    doi: 10.1210/jc.2018-00593

    Figure Lengend Snippet: Figure 2. Serum IGF2 isoform analysis. (A) WIB analysis of serum IGF2 in eight patients with SFT. Patients #1 to #5 are patients with SFT without hypoglycemia, and patients #10 to #12 are patients with SFT and hypoglycemia. Molecular size markers (in kilodaltons) are indicated by lines on the left. (B) Comparison of big IGF2 production levels between the non-NICTH group and the NICTH group. (C) Comparison of mature IGF2 production levels between the non-NICTH group and the NICTH group. (D) Comparison of the big IGF2/mature IGF2 production-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; P , 0.05 was accepted as significant in all panels.

    Article Snippet: Sections were also stained with an anti-IGF2 goat polyclonal antibody (AF-292-NA; R&D Systems, Minneapolis, MN) and an anti-PCSK4 rabbit polyclonal antibody (NBP1-88010; Novus Biologicals, Littleton, CO).

    Techniques: Comparison

    Figure 3. Comparative analysis of gene-expression levels in SFT using qRT-PCR. (A) IGF2 mRNA expression levels in the non-NICTH group and the NICTH group. (B) PCSK4 mRNA expression levels in the non-NICTH group and the NICTH group. (C) The IGF2/PCSK4 mRNA expression-level ratio in the non-NICTH group and the NICTH group. *P = 0.093, **P = 0.217, ***P = 0.006. P values were obtained using the t test. These values are not statistically significant but tentative as a result of the limited number of samples.

    Journal: The Journal of clinical endocrinology and metabolism

    Article Title: Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study.

    doi: 10.1210/jc.2018-00593

    Figure Lengend Snippet: Figure 3. Comparative analysis of gene-expression levels in SFT using qRT-PCR. (A) IGF2 mRNA expression levels in the non-NICTH group and the NICTH group. (B) PCSK4 mRNA expression levels in the non-NICTH group and the NICTH group. (C) The IGF2/PCSK4 mRNA expression-level ratio in the non-NICTH group and the NICTH group. *P = 0.093, **P = 0.217, ***P = 0.006. P values were obtained using the t test. These values are not statistically significant but tentative as a result of the limited number of samples.

    Article Snippet: Sections were also stained with an anti-IGF2 goat polyclonal antibody (AF-292-NA; R&D Systems, Minneapolis, MN) and an anti-PCSK4 rabbit polyclonal antibody (NBP1-88010; Novus Biologicals, Littleton, CO).

    Techniques: Gene Expression, Quantitative RT-PCR, Expressing

    Figure 4. Comparative analysis of protein expression levels in SFT by immunohistochemistry analysis. (A) Representative images of immunohistochemistry for IGF2. (B) Representative images of immunohistochemistry for PCSK4. (C) Comparison of IGF2 expression levels between the non-NICTH group and the NICTH group. (D) Comparison of PCSK4 expression levels between the non-NICTH group and the NICTH group. (E) Comparison of the IGF2/PCSK4 expression-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; (C and E) P , 0.05 was accepted as significant and is indicated in bold.

    Journal: The Journal of clinical endocrinology and metabolism

    Article Title: Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study.

    doi: 10.1210/jc.2018-00593

    Figure Lengend Snippet: Figure 4. Comparative analysis of protein expression levels in SFT by immunohistochemistry analysis. (A) Representative images of immunohistochemistry for IGF2. (B) Representative images of immunohistochemistry for PCSK4. (C) Comparison of IGF2 expression levels between the non-NICTH group and the NICTH group. (D) Comparison of PCSK4 expression levels between the non-NICTH group and the NICTH group. (E) Comparison of the IGF2/PCSK4 expression-level ratio between the non-NICTH group and the NICTH group. P values were obtained using the t test; (C and E) P , 0.05 was accepted as significant and is indicated in bold.

    Article Snippet: Sections were also stained with an anti-IGF2 goat polyclonal antibody (AF-292-NA; R&D Systems, Minneapolis, MN) and an anti-PCSK4 rabbit polyclonal antibody (NBP1-88010; Novus Biologicals, Littleton, CO).

    Techniques: Expressing, Immunohistochemistry, Comparison

    Expression of miR483-3p, IGF 2 and Smad4 in adrenocortical tumors

    Journal: Histopathology

    Article Title: Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers

    doi: 10.1111/his.12283

    Figure Lengend Snippet: Expression of miR483-3p, IGF 2 and Smad4 in adrenocortical tumors

    Article Snippet: Sections were incubated at 4°C overnight with anti-IGF2 goat polyclonal antibody (sc-1415; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) diluted at 1:100, anti-MIB-1 monoclonal antibody working liquid (ZM-0167, ZSGB-BIO, China), or anti-Smad4 rabbit monoclonal antibody (ab40759; Abcam, Cambridge, MA, USA) diluted at 1:100.

    Techniques: Expressing

    Representative staining for miR483-3p, IGF2 and Smad4 in adrenal cortical tumours. MiR483-3p was detected by in-situ hybridization (ISH), and IGF2 and Smad4 by immunochemistry. A, MiR483-3p in an adrenocortical carcinoma (ACC). The miR483-3p ISH signal is expressed mainly in the cytoplasm in all tumour cells of the ACC. Positive staining has a blue–violet colour. B, Perinuclear dot-like and homogeneous cytoplasmic staining for IGF2 in all or nearly all tumour cells in the same ACC correlating with the expression of miR483-3p (4+ staining). C, Smad4 in an ACC showing negative staining (score 0). Note positive labelling in the non-neoplastic fibrous tissue on the left. D, Negative miR483-3p ISH in an ACA. E, IGF2 in an ACA showing 1+ staining. Note intra-cytoplasmic specks only. F, An ACA displaying strong, diffuse cytoplasmic and occasional nuclear expression of Smad4.

    Journal: Histopathology

    Article Title: Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers

    doi: 10.1111/his.12283

    Figure Lengend Snippet: Representative staining for miR483-3p, IGF2 and Smad4 in adrenal cortical tumours. MiR483-3p was detected by in-situ hybridization (ISH), and IGF2 and Smad4 by immunochemistry. A, MiR483-3p in an adrenocortical carcinoma (ACC). The miR483-3p ISH signal is expressed mainly in the cytoplasm in all tumour cells of the ACC. Positive staining has a blue–violet colour. B, Perinuclear dot-like and homogeneous cytoplasmic staining for IGF2 in all or nearly all tumour cells in the same ACC correlating with the expression of miR483-3p (4+ staining). C, Smad4 in an ACC showing negative staining (score 0). Note positive labelling in the non-neoplastic fibrous tissue on the left. D, Negative miR483-3p ISH in an ACA. E, IGF2 in an ACA showing 1+ staining. Note intra-cytoplasmic specks only. F, An ACA displaying strong, diffuse cytoplasmic and occasional nuclear expression of Smad4.

    Article Snippet: Sections were incubated at 4°C overnight with anti-IGF2 goat polyclonal antibody (sc-1415; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) diluted at 1:100, anti-MIB-1 monoclonal antibody working liquid (ZM-0167, ZSGB-BIO, China), or anti-Smad4 rabbit monoclonal antibody (ab40759; Abcam, Cambridge, MA, USA) diluted at 1:100.

    Techniques: Staining, In Situ Hybridization, Expressing, Negative Staining

    Correlation between miR483-3p, IGF 2 or Smad4 expression and cellular proliferative activity

    Journal: Histopathology

    Article Title: Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers

    doi: 10.1111/his.12283

    Figure Lengend Snippet: Correlation between miR483-3p, IGF 2 or Smad4 expression and cellular proliferative activity

    Article Snippet: Sections were incubated at 4°C overnight with anti-IGF2 goat polyclonal antibody (sc-1415; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) diluted at 1:100, anti-MIB-1 monoclonal antibody working liquid (ZM-0167, ZSGB-BIO, China), or anti-Smad4 rabbit monoclonal antibody (ab40759; Abcam, Cambridge, MA, USA) diluted at 1:100.

    Techniques: Expressing, Activity Assay

    Clinical features and immunohistochemical results of the 15 borderline tumors

    Journal: Histopathology

    Article Title: Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers

    doi: 10.1111/his.12283

    Figure Lengend Snippet: Clinical features and immunohistochemical results of the 15 borderline tumors

    Article Snippet: Sections were incubated at 4°C overnight with anti-IGF2 goat polyclonal antibody (sc-1415; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) diluted at 1:100, anti-MIB-1 monoclonal antibody working liquid (ZM-0167, ZSGB-BIO, China), or anti-Smad4 rabbit monoclonal antibody (ab40759; Abcam, Cambridge, MA, USA) diluted at 1:100.

    Techniques: Immunohistochemical staining

    Nucleolus-enriched RNAs 1

    Journal: Nucleus

    Article Title: A mRNA and Cognate MicroRNAs Localize in the Nucleolus

    doi: 10.4161/19491034.2014.990864

    Figure Lengend Snippet: Nucleolus-enriched RNAs 1

    Article Snippet: This was performed as previously detailed using a polyclonal rabbit IgG for IGF2 ( Santa Cruz Biotechnology, Santa Cruz, CA) at a 1:25 dilution followed by visualization using a Cy3-conjugated donkey anti-rabbit IgG.

    Techniques: Binding Assay, Sequencing

    Fluorescence in situ hybridization. - : Cells incubated in buffer prior to hybridization; + : cells pre-incubated with RNase. A: IGF2 mRNA hybridization probes. B: 28 S rRNA probes. C: Scrambled sequence probes (see Materials and Methods). The upper panels in A-C are phase contrast images, the lower panels are the fluorescence microscopy images. Arrows indicate hybridization to IGF2 mRNA in nucleoli. (See also Figure S2 ).

    Journal: Nucleus

    Article Title: A mRNA and Cognate MicroRNAs Localize in the Nucleolus

    doi: 10.4161/19491034.2014.990864

    Figure Lengend Snippet: Fluorescence in situ hybridization. - : Cells incubated in buffer prior to hybridization; + : cells pre-incubated with RNase. A: IGF2 mRNA hybridization probes. B: 28 S rRNA probes. C: Scrambled sequence probes (see Materials and Methods). The upper panels in A-C are phase contrast images, the lower panels are the fluorescence microscopy images. Arrows indicate hybridization to IGF2 mRNA in nucleoli. (See also Figure S2 ).

    Article Snippet: This was performed as previously detailed using a polyclonal rabbit IgG for IGF2 ( Santa Cruz Biotechnology, Santa Cruz, CA) at a 1:25 dilution followed by visualization using a Cy3-conjugated donkey anti-rabbit IgG.

    Techniques: Fluorescence, In Situ Hybridization, Incubation, Hybridization, Sequencing, Microscopy

    Predicted binding sites of miR-206 in the 3′-UTR of IGF2 mRNA.

    Journal: Nucleus

    Article Title: A mRNA and Cognate MicroRNAs Localize in the Nucleolus

    doi: 10.4161/19491034.2014.990864

    Figure Lengend Snippet: Predicted binding sites of miR-206 in the 3′-UTR of IGF2 mRNA.

    Article Snippet: This was performed as previously detailed using a polyclonal rabbit IgG for IGF2 ( Santa Cruz Biotechnology, Santa Cruz, CA) at a 1:25 dilution followed by visualization using a Cy3-conjugated donkey anti-rabbit IgG.

    Techniques: Binding Assay

    Predicted binding sites of miR-351 in the 3′-UTR of IGF2 mRNA.

    Journal: Nucleus

    Article Title: A mRNA and Cognate MicroRNAs Localize in the Nucleolus

    doi: 10.4161/19491034.2014.990864

    Figure Lengend Snippet: Predicted binding sites of miR-351 in the 3′-UTR of IGF2 mRNA.

    Article Snippet: This was performed as previously detailed using a polyclonal rabbit IgG for IGF2 ( Santa Cruz Biotechnology, Santa Cruz, CA) at a 1:25 dilution followed by visualization using a Cy3-conjugated donkey anti-rabbit IgG.

    Techniques: Binding Assay

    Predicted binding sites of miR-494 and miR-340 in the 3′-UTR of IGF2 mRNA.

    Journal: Nucleus

    Article Title: A mRNA and Cognate MicroRNAs Localize in the Nucleolus

    doi: 10.4161/19491034.2014.990864

    Figure Lengend Snippet: Predicted binding sites of miR-494 and miR-340 in the 3′-UTR of IGF2 mRNA.

    Article Snippet: This was performed as previously detailed using a polyclonal rabbit IgG for IGF2 ( Santa Cruz Biotechnology, Santa Cruz, CA) at a 1:25 dilution followed by visualization using a Cy3-conjugated donkey anti-rabbit IgG.

    Techniques: Binding Assay

    Predicted binding sites of miR-664 in the 5′- and 3'-UTRs of IGF2 mRNA.

    Journal: Nucleus

    Article Title: A mRNA and Cognate MicroRNAs Localize in the Nucleolus

    doi: 10.4161/19491034.2014.990864

    Figure Lengend Snippet: Predicted binding sites of miR-664 in the 5′- and 3'-UTRs of IGF2 mRNA.

    Article Snippet: This was performed as previously detailed using a polyclonal rabbit IgG for IGF2 ( Santa Cruz Biotechnology, Santa Cruz, CA) at a 1:25 dilution followed by visualization using a Cy3-conjugated donkey anti-rabbit IgG.

    Techniques: Binding Assay

    Summary of predicted miRNA Targets in IGF 2 mRNA 1

    Journal: Nucleus

    Article Title: A mRNA and Cognate MicroRNAs Localize in the Nucleolus

    doi: 10.4161/19491034.2014.990864

    Figure Lengend Snippet: Summary of predicted miRNA Targets in IGF 2 mRNA 1

    Article Snippet: This was performed as previously detailed using a polyclonal rabbit IgG for IGF2 ( Santa Cruz Biotechnology, Santa Cruz, CA) at a 1:25 dilution followed by visualization using a Cy3-conjugated donkey anti-rabbit IgG.

    Techniques: Sequencing

    Comparison of the predicted rat myoblast miR-206:IGF2 mRNA interaction and that of miR-206 and KLF4 mRNA in human cells.

    Journal: Nucleus

    Article Title: A mRNA and Cognate MicroRNAs Localize in the Nucleolus

    doi: 10.4161/19491034.2014.990864

    Figure Lengend Snippet: Comparison of the predicted rat myoblast miR-206:IGF2 mRNA interaction and that of miR-206 and KLF4 mRNA in human cells.

    Article Snippet: This was performed as previously detailed using a polyclonal rabbit IgG for IGF2 ( Santa Cruz Biotechnology, Santa Cruz, CA) at a 1:25 dilution followed by visualization using a Cy3-conjugated donkey anti-rabbit IgG.

    Techniques: Comparison

    FIG. 5. Effect of H358-conditioned medium, AR, and IGF1 on IGF1-R tyrosine phosphorylation. Serum-deprived H322 cells were incubated: A, for 30 min in serum-free medium (), in serum-free medium with IGF1 50 ng/ml (IGF1), or for indicated times in serum-free H358 CM (CM); B, for 30 min in serum-free medium (), in H358 CM (CM), in H358 CM preincubated with anti-AR neutralizing antibody (CM Ac AR), or in serum-free medium with 50 ng/ml of IGF1 (IGF1) or AR (AR), prior to detergent lysis and immunoprecipitation of the IGF1-R subunit. C, serum-deprived H358 cells were incubated for 30 min in serum-free medium (), in H358 CM (CM), or in serum-free medium with 50 ng/ml of IGF1 (IGF1) or AR (AR), prior to detergent lysis and immunoprecipitation of the IGF1-R subunit. Tyrosine phos- phorylation was visualized by protein immunoblotting with monoclonal anti-phosphotyrosine IgG as described (upper lane). Equal loading of immunoprecipitated proteins was confirmed by reprobing immunoblots with polyclonal anti-IGF1-R subunit antibody (lower lane). IgG, im- munoglobulin control for immunoprecipitation. Data are representative of at least three separate experiments.

    Journal: Journal of Biological Chemistry

    Article Title: Inhibition of Apoptosis by Amphiregulin via an Insulin-like Growth Factor-1 Receptor-dependent Pathway in Non-small Cell Lung Cancer Cell Lines

    doi: 10.1074/jbc.m207584200

    Figure Lengend Snippet: FIG. 5. Effect of H358-conditioned medium, AR, and IGF1 on IGF1-R tyrosine phosphorylation. Serum-deprived H322 cells were incubated: A, for 30 min in serum-free medium (), in serum-free medium with IGF1 50 ng/ml (IGF1), or for indicated times in serum-free H358 CM (CM); B, for 30 min in serum-free medium (), in H358 CM (CM), in H358 CM preincubated with anti-AR neutralizing antibody (CM Ac AR), or in serum-free medium with 50 ng/ml of IGF1 (IGF1) or AR (AR), prior to detergent lysis and immunoprecipitation of the IGF1-R subunit. C, serum-deprived H358 cells were incubated for 30 min in serum-free medium (), in H358 CM (CM), or in serum-free medium with 50 ng/ml of IGF1 (IGF1) or AR (AR), prior to detergent lysis and immunoprecipitation of the IGF1-R subunit. Tyrosine phos- phorylation was visualized by protein immunoblotting with monoclonal anti-phosphotyrosine IgG as described (upper lane). Equal loading of immunoprecipitated proteins was confirmed by reprobing immunoblots with polyclonal anti-IGF1-R subunit antibody (lower lane). IgG, im- munoglobulin control for immunoprecipitation. Data are representative of at least three separate experiments.

    Article Snippet: Anti-human EGF or AR mouse monoclonal, anti-human TGF , betacellulin, or IGF2 goat polyclonal (R&D Systems Europe, Ltd., Abingdon, UK) or anti-human IGF1 goat polyclonal (Oncogene Research Products, Fontenay sous Bois, France) neutralizing antibodies were incubated overnight at 4 °C in H358 CM.

    Techniques: Phospho-proteomics, Incubation, Lysis, Immunoprecipitation, Western Blot, Control

    FIG. 6. Effect of EGFR inhibitors on IGF1-R tyrosine phosphorylation. Serum-deprived H322 cells were incubated for 30 min in serum-free medium (), in H358 CM (CM), or in serum-free medium supplemented with AR 50 ng/ml (AR) or with IGF1 50 ng/ml (IGF1), in the presence or absence of EGFR inhibitors AG556 20 (M) or ZD1839 (500 nM). Detergent lysis of proteins, immunoprecipitation of the IGF1-R subunit, and tyrosine phosphorylation Western blotting (upper lane) were then performed. Equal loading of immunoprecipitated proteins was confirmed by reprobing immunoblots with polyclonal anti-IGF1-R subunit antibody (lower lane). IgG, immunoglobulin control for immunopre- cipitation. Data are representative of three independent experiments.

    Journal: Journal of Biological Chemistry

    Article Title: Inhibition of Apoptosis by Amphiregulin via an Insulin-like Growth Factor-1 Receptor-dependent Pathway in Non-small Cell Lung Cancer Cell Lines

    doi: 10.1074/jbc.m207584200

    Figure Lengend Snippet: FIG. 6. Effect of EGFR inhibitors on IGF1-R tyrosine phosphorylation. Serum-deprived H322 cells were incubated for 30 min in serum-free medium (), in H358 CM (CM), or in serum-free medium supplemented with AR 50 ng/ml (AR) or with IGF1 50 ng/ml (IGF1), in the presence or absence of EGFR inhibitors AG556 20 (M) or ZD1839 (500 nM). Detergent lysis of proteins, immunoprecipitation of the IGF1-R subunit, and tyrosine phosphorylation Western blotting (upper lane) were then performed. Equal loading of immunoprecipitated proteins was confirmed by reprobing immunoblots with polyclonal anti-IGF1-R subunit antibody (lower lane). IgG, immunoglobulin control for immunopre- cipitation. Data are representative of three independent experiments.

    Article Snippet: Anti-human EGF or AR mouse monoclonal, anti-human TGF , betacellulin, or IGF2 goat polyclonal (R&D Systems Europe, Ltd., Abingdon, UK) or anti-human IGF1 goat polyclonal (Oncogene Research Products, Fontenay sous Bois, France) neutralizing antibodies were incubated overnight at 4 °C in H358 CM.

    Techniques: Phospho-proteomics, Incubation, Lysis, Immunoprecipitation, Western Blot, Control